Literature DB >> 11891676

Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development.

E Arikawa-Hirasawa1, W R Wilcox, Y Yamada.   

Abstract

Dyssegmental dysplasia, Silverman-Handmaker type (DDSH), is a lethal autosomal recessive form of dwarfism with characteristic anisospondylic micromelia. The remarkable similarities in the radiographic, clinical, and chondroosseous morphology of DDSH patients to those of perlecan-null mice led to the identification of mutations in the perlecan gene (HSPG2) of DDSH. Perlecan, a large heparan sulfate proteoglycan, is expressed in various tissues and is a component of all basement membrane extracellular matrices. A chondrodysplasia phenotype caused by the loss of perlecan was unexpected, because cartilage does not have basement membranes. Insertion and splicing mutations in HSPG2 of DDSH were found that were predicted to create a premature termination codon. Immunostaining and biochemical analysis revealed that the mutant perlecan molecules were unstable and not secreted into the extracellular matrix. These results indicate that DDSH is caused by functional null mutations of HSPG2 and that perlecan is essential for cartilage development. Published 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11891676     DOI: 10.1002/ajmg.10229

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  17 in total

Review 1.  The nature and biology of basement membranes.

Authors:  Ambra Pozzi; Peter D Yurchenco; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-12-28       Impact factor: 11.583

2.  Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.

Authors:  Muneaki Ishijima; Nobuharu Suzuki; Kentaro Hozumi; Tomoya Matsunobu; Keisuke Kosaki; Haruka Kaneko; John R Hassell; Eri Arikawa-Hirasawa; Yoshihiko Yamada
Journal:  Matrix Biol       Date:  2012-03-07       Impact factor: 11.583

3.  Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept.

Authors:  Maria A Gubbiotti; Renato V Iozzo
Journal:  Matrix Biol       Date:  2015-10-14       Impact factor: 11.583

4.  Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.

Authors:  Zhuo Xu; Naoki Ichikawa; Keisuke Kosaki; Yoshihiko Yamada; Takako Sasaki; Lynn Y Sakai; Hisashi Kurosawa; Nobutaka Hattori; Eri Arikawa-Hirasawa
Journal:  Matrix Biol       Date:  2010-06-09       Impact factor: 11.583

Review 5.  Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.

Authors:  Mary C Farach-Carson; Curtis R Warren; Daniel A Harrington; Daniel D Carson
Journal:  Matrix Biol       Date:  2013-08-31       Impact factor: 11.583

6.  Topographical variation in the distributions of versican, aggrecan and perlecan in the foetal human spine reflects their diverse functional roles in spinal development.

Authors:  Susan M Smith; John M Whitelock; Renato V Iozzo; Christopher B Little; James Melrose
Journal:  Histochem Cell Biol       Date:  2009-08-11       Impact factor: 4.304

Review 7.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

Review 8.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

9.  The core protein of growth plate perlecan binds FGF-18 and alters its mitogenic effect on chondrocytes.

Authors:  Simone M-L Smith; Leigh A West; John R Hassell
Journal:  Arch Biochem Biophys       Date:  2007-10-22       Impact factor: 4.013

Review 10.  A current view of perlecan in physiology and pathology: A mosaic of functions.

Authors:  Maria A Gubbiotti; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.